Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome: A preliminary study

Neurogastroenterology and Motility

Volumn 23, Issue 4, 2011, Pages

  Shimizu, K ^a   Ogura, H ^b   Asahara, T ^c   Nomoto, K ^c   Morotomi, M ^c   Nakahori, Y ^b   Osuka, A ^b   Yamano, S ^b   Goto, M ^b   Matsushima, A ^d   Tasaki, O ^b   Kuwagata, Y ^b   Sugimoto, H ^e  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^d CHUKYO HOSPITAL   (Japan)

^e HOSHIGAOKA KOSEINENKIN HOSPITAL   (Japan)

Author keywords

Flora; Motility; Sepsis; Short chain fatty acids; Systemiinc flammatory response syndrome; Translocation

Indexed keywords

ACETIC ACID; LACTIC ACID; PROPIONIC ACID; SUCCINIC ACID;

ADULT; ARTICLE; BACTEREMIA; BACTEROIDACEAE; BIFIDOBACTERIUM; BURN; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ENCEPHALITIS; ENTERITIS; FECES MICROFLORA; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; HUMAN; INJURY; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MORTALITY; NASOGASTRIC TUBE; NECROTIZING FASCIITIS; NOSE FEEDING; NUTRITIONAL INTOLERANCE; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; BACTEROIDACEAE; BIFIDOBACTERIUM; EATING DISORDERS; ENTERAL NUTRITION; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; STAPHYLOCOCCUS; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 79954587700     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01653.x     Document Type: Article

References (29)

1. Fruhwald S, Holzer P, Metzler H. Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact. Intensive Care Med 2007; 33: 36-44.
2. Quigley EM Critical care dysmotility: abnormal foregut motor function in the ICU/ITU patient. Gut 2005; 54: 1351-2; Discussion 84-90.
3. Montejo JC. Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units. Crit Care Med 1999; 27: 1447-53.
4. Herbert MK, Holzer P. Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients--current status and future options. Clin Nutr 2008; 27: 25-41.
5. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.
6. Shimizu K, Ogura H, Goto M et al. Altered gut flora and environment in patients with severe SIRS. J Trauma 2006; 60: 126-33.
7. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
8. Nguyen NQ, Chapman M, Fraser RJ, Bryant LK, Burgstad C, Holloway RH. Prokinetic therapy for feed intolerance in critical illness: one drug or two? Crit Care Med 2007; 35: 2561-7.
9. Azuma R, Suto T. Validity of transfer of the taxonomical position of Corynebacterium pseudopyogenes from genus Corynebacterium to genus Actinomyces. In: Izuka H, Hasegawa T, eds. Proceeding of the First International Conference on Culture Collection. Tokyo: University of Tokyo Press, 1970: 866-69.
10. Tanaka R, Mutai M. Improved medium for selective isolation and enumeration of Bifidobacterium. Appl Environ Microbiol 1980; 40: 866-9.
11. Petts DN. Colistin-oxolinic acid-blood agar: a new selective medium for streptococci. J Clin Microbiol 1984; 19: 4-7.
12. Moore WE, Cato EP, Holdeman LV. Some current concepts in intestinal bacteriology. Am J Clin Nutr 1978; 31: S33-42.
13. Sugawara G, Nagino M, Nishio H et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006; 244: 706-14.
14. Kikuchi H, Yajima T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Food Agr 1992; 60: 139-46.
15. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32.
16. Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother 1994; 38: 409-14.
17. Shimizu K, Ogura H, Goto M et al. The persistent decrease of total obligate anaerobes in gut is related to the high mortality in patients with severe SIRS. Crit Care Med 2006; 34(Suppl.): A1.
18. Barbara G, Stanghellini V, Brandi G et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005; 100: 2560-8.
19. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001; 280: G368-80.
20. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881-4.
21. Kassinen A, Krogius-Kurikka L, Makivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
22. Verdu EF. Probiotics effects on gastrointestinal function: beyond the gut? Neurogastroenterol Motil 2009; 21: 477-80.
23. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223-8.
24. Runkel NS, Moody FG, Smith GS et al. Alterations in rat intestinal transit by morphine promote bacterial translocation. Dig Dis Sci 1993; 38: 1530-6.
25. Rémésy C, Demigné C, Morand C. Metabolism of short chain fatty acids in the liver. In: Cummings JH, Rombeau JL, Sakata T, eds. Physiological and Clinical Aspects of Short-chain Fatty Acids. UK: Cambridge University Press, 1995: 171-90.
26. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003; 62: 67-72.
27. Kamath PS, Phillips SF, Zinsmeister AR. Short-chain fatty acids stimulate ileal motility in humans. Gastroenterology 1988; 95: 1496-502.
28. Sakata T, Ichikawa H, Inagaki A. Influences of lactic acid, succinic acid and ammonia on epithelial cell proliferation and motility of the large bowel. Asia Pac J Clin Nutr 1999; 8(Suppl.): S9-S13.
29. Shimizu K, Ogura H, Goto M et al. Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report. Dig Dis Sci 2009; 54: 1071-8.